Download Citation
Article Source:
A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant
Ramalingam S,
Siamakpour-Reihani S,
Bohannan L,
Ren Y,
Sibley A,
et al.
(2021)
A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.
PLOS ONE 16(6): e0252995.
https://doi.org/10.1371/journal.pone.0252995